GENTRACK GROUP LTD (GTK) ACQUISITION OF EVOLVE ANALYTICS

whitePaper | June 16, 2022

It seems like the business world has gone crazy for machine learning (ML) and artificial intelligence (AI), viewing the technologies as the essential keys to the very future of the enterprise. In fact, a recent survey from ESIThoughtLab found that two-thirds of business leaders see AI as critically important for their future. And yet, the respondents report that only 25% of AI projects are in widespread deployment and 40% of all projects are generating negative or no returns.

whitePaper | October 1, 2021

centering your database and data analytics workload development and deployment on a Kubernetes-based container, you can create a more efficient and speedy data life cycle. Access this white paper to learn how to improve key capabilities for database and data analytics workloads across hybrid cloud environments.

whitePaper | October 18, 2022

We talk about striving to be data driven. But in doing so, we’ve skipped an important step. Today, we must first aspire to be data-sharing organizations. That means becoming businesses where data is easily and proactively shared with every relevant person. Otherwise, there will be no driving possible. We’ll be left in the dust, lacking the gas — the data — to fuel us ahead in the digital economy. Gartner® said, “According to the Sixth Annual Gartner Chief Data Officer Survey,1 respondents who successfully increased data sharing led D&A teams that were 1.7 times more effective at showing demonstrable, verifiable value to D&A stakeholders.”

whitePaper | November 26, 2019

Modernized organizations are leveraging the transformative benefits of predictive analytics to propel their business forward. Predictive analytics arm you with knowledge and insights that can make the difference between profits and losses. They use modeling, machine learning, and artificial intelligence to analyze current data and make predictions about the future. Every industry can benefit from predictive analytics. Those who ignore the potential here are squandering a huge opportunity to grow or create better experiences. The recent dramatic progress in AI-based predictive analytics and machine learning provides organizations with the power to unlock tremendous value from previously hard to decipher data. Through the power of AI-enabled infrastructure, you can harness the predictive analytics/machine learning wave and gain business advantages that will not only keep you in the game, but at the leading edge. Automated server capabilities and the right server for the job will get you where you need to go. This eBook focuses in on how server automation, along with the right servers for the workload, empowers companies to make great strides in the world of machine learning and predictive analytics.

whitePaper | December 27, 2022

The 2022 data industry white paper consists of five parts. Part 1 discusses data sharing between individuals, across countries and within companies, under this year's theme of 'Data Sharing.' Part 2 summarizes the major policies, legislation, and systems related to the data industry in Korea and abroad. Part 3 deals with the current status of Korean and global data industry markets. In Part 4, the status of each industry based on business data is examined. Part 5 reviews technologies related to data sharing and utilization. Overall, this white paper uses infographics to summarize the flow of related policies, legislations, and institutions that have been promoted over five years, and highlights the main data issues experienced in Korea this year based on data analysis.

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.